SonoSite (SONO) Receives FDA Clearance for Its NanoMaxx Ultrasound System
More News related to SONO
- SonoSite Schedules Fourth Quarter 2009 Financial Release and Conference Call
- SonoSite (SONO) to Begin Repurchase of $100M in Common Shares Through 'Dutch Auction' Tender Offer
- SonoSite Announces Commencement of $100 Million Common Stock Tender Offer
- SonoSite (SONO) Authorizes $150M Common Stock/Convertible Notes Buyback
- SonoSite Announces Planned Tender Offer to Repurchase $100 Million of Common Stock
More News related to FDA
- AspenBio Pharma (APPY) Reports Results from Interim Analysis for Ongoing Trial of AppyScore
- XenoPort (XNPT) Said FDA Moves PDUFA Date Due to February 11
- Dendreon (DNDN) CEO Says Provenge Salesforce Will Be 125 People, Sees Full Manufacturing Ability by Mid-2011
- U.S. FDA to Become More Stringent on Medical Imaging Equipment (GE, SI)
- BSD Medical (BSDM) Initiates Phase 3 Clinical Study of BSD-2000 Hyperthermia System
SonoSite, Inc. (Nasdaq: SONO) has received FDA 510(k) clearance for its new NanoMaxx(TM) ultrasound system and is commencing US customer deliveries. International deliveries began at the end of June.
Based on SonoSite's 4th generation Turbo technology, the six pound NanoMaxx system is the latest addition to SonoSite's suite of specialized products for point-of-care visualization in medicine. Complete with streamlined one button optimization technology, a touch screen user interface and SonoSite's industry-leading 5-year warranty, the NanoMaxx system is ideal for both hospital and office markets and designed to provide healthcare professionals with improved patient safety practices, expanded workflow capabilities and exam room flexibility.
[SM]
Related Categories
FDAStocks Mentioned
+0.21Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
